IOANA RUIZ ARRUZA-rekin lankidetzan egindako argitalpenak (15)

2024

  1. Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Arthritis Care and Research

2023

  1. ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 928-935

2021

  1. Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort

    Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 249-257

2020

  1. Ankle-brachial index and arterial vascular events in systemic lupus erythematosus patients: A 5-year prospective cohort

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 978-984

  2. Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus

    Lupus, Vol. 29, Núm. 10, pp. 1155-1167

2019

  1. Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts

    Autoimmunity Reviews, Vol. 18, Núm. 9

2018

  1. Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

    Rheumatology (Oxford, England)

  2. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study

    Arthritis Care and Research, Vol. 70, Núm. 4, pp. 582-591

2017

  1. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: Results of an international multicentre study

    Lupus, Vol. 26, Núm. 3, pp. 266-276

  2. Predictors of peripheral arterial disease in SLE change with patient's age

    Lupus Science and Medicine, Vol. 4, Núm. 1

2015

  1. Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis

    Autoimmunity Reviews, Vol. 14, Núm. 10, pp. 875-879

2014

  1. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus

    Rheumatology (United Kingdom), Vol. 53, Núm. 8, pp. 1470-1476

2012

  1. Task force report on the management of thrombosis in antiphospholipid syndrome

    Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies (Springer US), pp. 167-179

2011

  1. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

    Lupus

2009

  1. Predictors of major infections in systemic lupus erythematosus.

    Arthritis research & therapy, Vol. 11, Núm. 4